Background: Prostate-specific antigen (PSA) testing for prostate cancer is controversial, with concerning rates of both overscreening and underscreening. The reasons for the observed rates of screening are unknown, and few studies have examined the relationship of psychological health to PSA screening rates. Understanding this relationship can help guide interventions to improve informed decision-making for screening.
P rostate-specific antigen (PSA) testing has been used to screen men for prostate cancer (PCa) since the early 1990s. 1 Despite its regular use, PSA screening remains controversial due to its uncertain mortality benefits and the possible exposure of men to unnecessary treatments and related toxicities. 2 Recent large, randomized controlled trials on the mortality benefits of PSA screening have failed to resolve the controversy, 3, 4 but data suggest that men with at least a 10-year remaining life expectancy (RLE) would have a disease-specific mortality benefit from PSA screening. 3, 5 As a consequence, guidelines emphasize the necessity for informed decision-making (IDM). For example, both the American Cancer Society and the American Urological Association recommend that men with an RLE of at least 10 years have an opportunity to make an informed decision about being screened for PCa. 6, 7 In contrast, US Preventive Services Task Force guidelines recommend against routine PSA-based screening for PCa. 8 Whatever the differences in recommendations, all emphasize the importance of a shared, IDM process.
Despite this emphasis on IDM, multiple studies show that well over 30% of men with limited RLE and/or multiple comorbidities continue to be screened. 2 Conversely, a similarly large percentage of men with long RLE and few comorbidities, for whom informed decisions resulting in PSA testing are potentially "appropriate," are not receiving PSA tests. 9 Proposed associations with inappropriate screening include difficulty for physicians in predicting RLE, 10 and exposure to the "do-something" health care system. 9, 11 Nevertheless, it remains unclear why there is such variability in non-RLE-based PSA screening rates.
It has been suggested that a patient's psychological state may influence cancer screening rates as emotions are known to affect health behavior, self-regulation, and uptake of health-related messages. 12 For example, heightened anxiety has consistently predicted breast cancer screening rates. 12 In the more limited studies on PCa screening in men, an inconsistent relationship has been found between anxiety and screening, likely due to small sample sizes, selected populations, or different measures of anxiety. 13 One hospitalbased study found that higher anxiety increased PSA screening rates in men, particularly for those with a family history of PCa seeking reassurance from a normal test result. 14 Conversely, another study found a marginally significant, "inverted U"-shaped relationship between PSA screening and trait anxiety; men with both very low (ie, no concern) or very high (ie, fear) anxiety levels had lower screening rates, whereas individuals with moderate anxiety levels had the highest screening rates. 15 Others show anxiety associated with decreased screening rates, possibly due to fear and avoidance of threatening situations. 16, 17 Still other studies have shown no relationship between trait anxiety and PSA screening. 16 Depressive symptoms may also play a role in cancer screening behavior. Individuals with elevated depressive symptoms have lower overall rates of preventive care utilization and adherence to treatments, 18, 19 despite using more health care services overall. 20 With regard to cancer screening, women with depressive symptoms have been found to have lower screening mammogram rates. 21, 22 In men, the relationship between depression and cancer screening remains largely unknown. One study on colorectal cancer screening found a decreased screening rate for men with depressive symptoms. 21 Finally, perceived stress may play a role in cancer screening as increased stress has been associated with other preventive health behaviors such as increased smoking rates, increased dietary fat intake, and decreased exercise likelihood. 23 One study examining the relationship between the likelihood of mammograms in those with psychological distress (a combined depressive and perceived stress symptoms measure) found decreased screening rates with increasing stress symptoms. 24 However, no similar study has been conducted for PSA screening in men.
Previous studies have much more frequently focused on women, making an investigation of the relationship of psychological health to cancer screening behavior in men needed since each gender may be different. Reasons include differences in cancer incidence and detection patterns, perceptions of cancer risk, 25 likelihoods of engaging in risky behaviors, 26 and psychological distress influencing self-perception of health. 27 The research on psychological health and PSA screening rates has been limited to small, nonrepresentative samples of men. In addition, previous research has focused almost entirely on anxiety, and very few studies have examined the role of other psychological states, such as depression and stress, on PSA screening rates. Understanding the relationship of different psychological states to PSA screening rates could help to direct interventions aimed at improving IDM. Identification of psychological factors that influence screening can also help guide physicians toward more appropriately screening men with longer RLE or less frequent, potentially harmful, screenings for men with limited RLE. In summary, patients' psychological states currently have unclear relationships with cancer screening patterns in men, little empirical research has examined the role of psychological health-including anxiety, depression, or stress-on PSA screening, and none have been done in a nationally representative population.
In response, this study uses a nationally representative dataset, the National Social Life Health and Aging Project (NSHAP), to examine the role of patient anxiety, depression, and stress using validated measures on PSA screening rates. We hypothesize that: (1) anxiety has a curvilinear relation-ship with screening in which individuals with both low and high anxiety symptoms will have decreased screening rates, whereas those with moderate anxiety levels will have increased screening rates; (2) those with increased depressive symptoms will have decreased screening rates; and (3) those with increased perceived stress symptoms will have decreased screening rates.
METHODS

Study Sample
This study uses data from the first wave (2005) of the NSHAP, a nationally representative, community-based survey of 3005 individuals aged 57-85 years old with interviews conducted in [2004] [2005] . An overall sample of 4400 individuals was approached for potential enrollment in NSHAP, and there was a 75.5% weighted response rate representing 3005 total respondents. Full details of the sample design are reported elsewhere. 28 For this sample, the women were removed, yielding 1455 men available from the NSHAP dataset. Men with missing information on primary variables (n = 125) or with a reported history of PCa or prostatectomy (n = 161) were excluded from our analysis, yielding a final sample size of 1169 men.
Dependent Variable-PSA Screening
The primary outcome measure is the self-reported receipt of a PSA screening test during the previous year, indicating appropriate screening for otherwise healthy men according to multiple guidelines at the time of data collection. 7, 29 This was assessed using the question, "About how long has it been since you last had a Prostate Specific Antigen test, also called a PSA test?"
Independent Variables-Psychological Assessments
Three separate, validated psychological scales were included in NSHAP to assess symptoms of anxiety, depression, and stress. 30 Anxiety was assessed using a 7-item modified version of the Hospital Anxiety and Depression Scale, Anxiety subscale (HADS-A). The measure assessed anxiety using a 0-3 Likert scale, giving a range of 0-21. The HADS-A has been shown to successfully assess symptom severity and identify cases of clinical anxiety, 31 as well as have acceptable reliability and validity on a population level. 30 The standardized Cronbach a coefficient for the modified version, indicating internal consistency and reliability, was 0.76, and a full account of the validity and acceptability of the modified HADS-A used for NSHAP is available elsewhere. 30 Anxiety was assessed as a categorical variable for descriptive analysis, and included the previously validated categories 0-7 (normal anxiety), 8-10 (mild anxiety), and 11+ (moderate/severe anxiety), 32 with the mild anxiety score (Z8) being a reliable cutoff for identifying cases of significant anxiety. 31 Depression was measured using the Center for Epidemiological Studies-Depression (CES-D) scale, a commonly used tool for assessing depressive symptoms on a population level. Specifically, NSHAP used the 11-item "Iowa form" of the CES-D scale, which has been validated in populationbased studies, including in older populations. 33 Responses to questions were on a 0-3 Likert scale, giving a possible range of 0-33. The standardized Cronbach a was 0.80 in the NSHAP sample. 30 In the full 20-item CES-D scale, which has a range of 0-60, a 16+ point cutoff is most commonly used to identify clinical cases of depression, which corresponds to 9+ points in the 11-item scale. 33 Other studies have shown that for elderly populations, a cutoff point of 21+ for the full CES-D scale is more appropriate, 34 which corresponds to approximately 12 points on the 11-item scale. Therefore, based on previous literature, 35 categorical variable cutoffs were defined as 0-8 (normal), 9-11 (mild depression), and 12+ (moderate/severe depression) for descriptive analysis.
Stress was assessed using a 4-item modified version of Cohen's Perceived Stress Scale (PSS-4). The PSS scale is a widely used measure of a global perception of stress, and questions focus on control over one's life, self-confidence, and perception of life events. 36 The modified PSS-4 scale focuses more on the perception of external stressors and ability to cope, rather than on general distress resulting from stress, 37 distinguishing itself from the CES-D and HADS-A for which negative affective states are more relevant. The modified NSHAP version of the PSS-4 had a Cronbach a of 0.63, and relevant validity and acceptability data are summarized elsewhere. 30 Questions were answered on a 0-3 Likert scale, giving a possible range of 0-12. There are no specific cutoff points for the modified PSS-4, however, previous studies have used dichotomous categories of 0-5 (low stress) and 6+ (high stress). 38 Stress was, therefore, measured as a dichotomous categorical variable in descriptive analysis. To facilitate interpretation, each psychological scale was standardized to have a mean of 0 and an SD equal to 1 before inclusion in the logistic regression models.
Health Status
Health status was assessed using a modified Charlson comorbidity index. The Charlson index was chosen because it is commonly used to assess worse health on the population level, and its survey form is well validated, relatively simple to use, and has been tied to mortality. 39, 40 In addition, comorbidity indices have been recommended to physicians as a means to estimate RLE for guideline-based PSA screening, 41 making it a clinically relevant estimate physicians may utilize in determining which patients should be offered PSA screening.
Covariates
Several variables are associated with PSA screening and were included in the logistic regression models. Age was incorporated as both a linear and quadratic term in the regression models due to its curvilinear relationship to PSA screening. Ethnicity, marital status, education, and income have all been previously associated with PSA screening and psychological health status. 1 Ethnicity was categorized as white, African American (AA), Hispanic, or Other. Marital status was classified as married or unmarried, where unmarried includes never married, widowed, and divorced men. Education was divided into 4 categories: "less than high school," "high school diploma/GED," "some college/vocational degree," or "Bachelors or more." Income was categorized based on the percentage of the Federal poverty level (FPL) for singleadult and 2-adult households in 2005, 42 with the categories "poor" (0%-100% FPL), "near-poor" (101%-200% FPL), and "not poor" (201% or more of the FPL). Health service utilization has also been described as an important potential confounder in the relationship between psychological distress and screening. 11, 20, 43 Health care utilization was measured using the reported number of visits to a doctor in the last 12 months.
Statistical Analysis
The rate of PSA screening was computed separately for subgroups based on each of the covariates. Separate logistic regressions were then used to evaluate the relationship between each psychological measure and the likelihood of screening, controlling for age (both linear and quadratic terms), race/ethnicity, marital status, education, visits to the doctor and comorbidity index. Interaction terms between each psychological measure and the number of doctor visits were tested, as were quadratic effects for each measure (to capture potential nonlinearities in the relationships between these measures and the likelihood of screening). A combined model was then fit including all 3 measures. Marginal probabilities of screening based on the combined model were computed separately by age and selected values of the psychological measures. Finally, poverty status was added to the combined model, and the model was refit using multiple imputations to account for the missing data in household income and each of the psychological measures. Imputation using chained equations was used, imputing each psychological measure by linear regression and household income by interval regression using information from the unfolding bracket questions that were administered when a respondent did not provide a specific dollar amount. Because the final model included an interaction between anxiety and visits to the doctor, imputation was performed separately for each category of doctor visits. 44 A burn-in period of 20 iterations was used for each chain, and 20 sets of imputations were generated. Sampling weights and design-based SEs using the linearization method were used throughout, based on the weight, strata, and PSU variables distributed with the dataset. All statistical analyses were performed using Stata 12.1. 45 
RESULTS
Sample Characteristics and PSA Screening Rates
Age had both a linear and a curvilinear relationship with PSA screening, in which men less than 60 years old and 80-85 years old had low PSA screening rates compared with those in age categories inbetween. Clinical variables had marked trends with screening. Those who had more physician visits were screened more often, with 41.3% being screened if visiting the doctor once, and 70.2% being screened if visiting the doctor 10+ times. Individuals with higher comorbidity scores also received more screening, where those with a score of 0 had a rate of 45.9% and those with a score of 5+ had a screening rate of 57.9% (Table 1) .
Considering the established cutoff levels on the HADS for having clinically significant anxiety, 10.5% of men were above the mild and greater categories. Similarly for depression on the CES-D, 10.3% of men had moderate/severe depression at a level above the established clinical cutoff for older adults. For perceived stress on the PSS, 6.9% of men had an elevated score. There was substantial variation in screening by each psychological variable. Individuals with normal levels of anxiety symptoms had a screening rate of 55.6%, whereas those with moderate/severe anxiety had a rate of 42.0%. There was a negative trend with increased depressive symptoms, with a rate of 54.4% in the normal category compared with 42.2% in moderate/severe category. Finally, men with low stress had screening rates of 56.1%, whereas those with high stress levels had much lower PSA screening at 39.1%.
Logistic Regression Results
In separate models for each psychological measure, quadratic terms were nonsignificant for anxiety (P = 0.90), depressive symptoms (P = 0.85), and stress (P = 0.71) ( Tables 2 and 3 ). A significant interaction between anxiety and number of doctor visits was found (P = 0.003); however, the corresponding interactions for stress and depressive symptoms were not significant (P = 0.34 and 0.58, respectively). A quadratic term for age was narrowly significant in the combined model (P = 0.05), and was included throughout (Fig. 1A) .
By itself, having depressive symptoms was negatively associated with the likelihood of screening [odds ratio (OR) = 0.81, P = 0.003]; however, this effect was diminished when adding stress to the model (OR = 0.88, P = 0.17) ( Table 2 ). Stress was also negatively associated with screening, and the estimated effect was identical in both the separate and combined models (OR = 0.76, P = 0.003) ( Fig. 1B) . Anxiety was negatively associated with screening for those who visited the doctor once or less during the previous year (OR = 0.61, P = 0.02 for those who visited the doctor once), and positively associated with screening for those who visited the doctor 10+ times (OR = 1.78, P = 0.02) (Fig. 2) .
For those with an anxiety score near the mean, the likelihood of screening increased steadily with the number of doctor visits. Those without a high school degree were less likely to have been screened. Race/ethnicity, marital status, and the comorbidity index were not associated with screening. Adding poverty status to the model and re-estimating using multiple imputation yielded very similar results (Table 3 ). Those below the FPL were less likely to be screened, and adding poverty status to the model diminished the estimated effect of education.
DISCUSSION
As hypothesized, we found a substantial, independent, linear relationship between increasing levels of perceived stress and lower rates of PSA screening in this nationally representative sample of older men. We also found that increased depressive symptoms decreased the likelihood of being screened, but this relationship was no longer significant after accounting for perceived stress. Finally, we found a strong, significant relationship between anxiety and PSA screening that differed depending on the number of doctor visits. To our knowledge, the relationship between perceived stress and screening and the impact of anxiety on screening depending on health care utilization have not been previously shown.
Men with increased perceived stress scores had a 17 percentage point difference in PSA screening rates compared with men with low perceived stress. There are some potential mechanisms that may explain the relationship. Stress has been linked to a reduced ability to appreciate long-term health goals, and stressed individuals therefore focus on short-term risk-averse behaviors, such as (avoiding) screening. 23 In addition, older individuals perceive greater barriers to health care services, even with good access, 46 and when combined with increased perception of external stressors, may have difficulty navigating the health care system. Further research examining the relationship of perceived stress to health care utilization is needed.
There was a significant interaction between anxiety levels and visits to the doctor, leading to different impacts on screening rates. Men with less doctor visits and high anxiety had lower screening rates, whereas men with more doctor visits and high anxiety had higher screening rates. It is important to consider both the source of anxiety, as well as the time course of symptom progression, when interpreting this relationship. 13 For example, in men who have anxiety about the screening process, anxiety is associated with avoidance and less screening, at least in community studies. 16, 17 In contrast, men with anxiety about PCa utilize more screening services due to seeking peace of mind, regardless of the appropriateness of screening, at least in hospital-based studies. 14 Therefore, despite the importance of physicians in the communication process regarding PSA screening, 43 patient anxiety may importantly influence the decision-making process. Our findings support both results, thereby drawing together seemingly disparate previous findings. We found that men with depressive symptoms have more than a 10 percentage point lower rate of PSA screening, consistent with prior research showing a decreased likelihood of obtaining preventive health services, mammograms, and colorectal cancer screenings in women. 19, 22 However, this relationship was no longer statistically significant when the regression included perceived stress, suggesting it as a mediator between depressive symptoms and screening behavior. This is consistent with prior work showing that individuals with depression utilize less preventive care services, primarily due to a higher perception of care barriers. 47 The relationship between stress, depression, and PSA screening is interesting in light of previous research showing that men with greater psychological distress generally utilize more health services, not less. 20 These findings have important policy implications for improving IDM regarding cancer screening in men. It is important to identify perceived stress and account for its impact on screening, especially for those also having depression. Organizational structures, such as collaborative care models which accommodate the needs of depressed or stressed patients, may importantly reduce perceived barriers. 48 In addition, physicians must be aware that patient psychological characteristics may drive screening decisions, regardless of the appropriateness of screening in an individual situation. Indeed, physicians may need to recognize and actively engage men with psychological morbidity in communication. 49 Strategies like motivational interviewing, 47 can overcome psychological barriers to treatment adherence, encourage appropriate IDM, and improve the likelihood of appropriate screening. In summary, interventions must take into account patients' psychological state to adequately empower patients to make informed decisions.
Our study has several limitations. First, it utilizes selfreported PSA screening rates, which may be subject to inaccuracies like recall bias. 50 Nevertheless, our estimated rates of PSA screening are consistent with other studies. 1, 2 Second, the NSHAP (2005) dataset is cross-sectional, which limits causal inferences. This limitation may be partially addressed using future waves of NSHAP (2010) that would add longitudinal data. However, self-selection bias, in which those with more psychological morbidity have decreased participation in the study, may not be fully addressed, even with longitudinal data. Third, there are shifting opinions about the appropriateness of PSA screening, so it is unclear what screening regimen is appropriate. Nevertheless, our findings are likely to be general for other, more obviously appropriate screening services, so the importance of psychological morbidity to screening is important.
In conclusion, we found that high perceived stress levels have a strong, independent, and negative association with PSA screening rates in a large, nationally representative sample. Although we replicated the relationship between depression and decreased screening shown in previous studies, this relationship was no longer significant after controlling for perceived stress, suggesting stress as the more important influence. Finally, we found a strong interaction effect between anxiety, health care utilization, and PSA screening rates. These findings have important implications for IDM, suggesting that the recognition and treatment of psychological morbidity may improve screening decisions. Future research should focus on interventions that can best address psychological influences on appropriate screening.
